Doganay Gizem D, Doganay Mehmet
Department of Moleculary Biology and Genetics, Istanbul Technical University, Istanbul, Turkey.
Recent Pat Antiinfect Drug Discov. 2013 Apr;8(1):27-33. doi: 10.2174/1574891x11308010006.
Perception on bioterrorism has changed after the deliberate release of anthrax by the postal system in the United States of America in 2001. Potential bioterrorism agents have been reclassified based on their dissemination, expected rate of mortality, availability, stability, and ability to lead a public panic. Brucella species can be easily cultured from infected animals and human materials. Also, it can be transferred, stored and disseminated easily. An intentional contamination of food with Brucella species could pose a threat with low mortality rate. Brucella spp. is highly infectious through aerosol route, making it an attractive pathogen to be used as a potential agent for biological warfare purposes. Recently, many studies have been concentrated on appropriate sampling of Brucella spp. from environment including finding ways for its early detection and development of new decontamination procedures such as new drugs and vaccines. There are many ongoing vaccine development studies; some of which recently received patents for detection and therapy of Brucella spp. However, there is still no available vaccine for humans. In this paper, recent developments and recent patents on brucellosis are reviewed and discussed.
2001年美国邮政系统蓄意投放炭疽后,人们对生物恐怖主义的认知发生了变化。潜在的生物恐怖主义制剂已根据其传播方式、预期死亡率、可得性、稳定性以及引发公众恐慌的能力进行了重新分类。布鲁氏菌属可轻易从受感染动物和人类材料中培养出来。此外,它易于转移、储存和传播。用布鲁氏菌属故意污染食物可能构成低死亡率的威胁。布鲁氏菌属通过气溶胶途径具有高度传染性,使其成为一种有吸引力的病原体,可作为生物战的潜在制剂。最近,许多研究集中在从环境中对布鲁氏菌属进行适当采样,包括寻找早期检测方法以及开发新的去污程序,如新药和疫苗。目前有许多正在进行的疫苗研发研究;其中一些最近获得了布鲁氏菌属检测和治疗的专利。然而,仍然没有可供人类使用的疫苗。本文对布鲁氏菌病的最新进展和近期专利进行了综述和讨论。